Moderna is a biotechnology company that develops & manufactures messenger RNA (mRNA) therapeutics & vaccines.
Moderna's technology involves using mRNA to instruct cells to produce proteins that trigger an immune response to a particular disease or condition.
The company was founded in 2010 & is headquartered in Cambridge, Massachusetts.
In 2020, Moderna made history by developing one of the first COVID-19 vaccines to receive emergency use authorization by the U.S.
Food and Drug Administration (FDA) & has since been approved for use in several other countries.
The vaccine has been shown to be highly effective in preventing COVID-19 & has been credited with helping to slow the spread of the virus worldwide.
Moderna is also working on developing mRNA-based treatments for a variety of other diseases, including cancer, heart disease, & rare genetic disorders.
The company's innovative approach to drug development has the potential to revolutionize the way many diseases are treated & has garnered significant attention & investment from the pharma industry.